Catherine L Nutt
Overview
Explore the profile of Catherine L Nutt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1582
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Betensky R, Szymonifka J, Lee E, Nutt C, Batchelor T
Stat Med
. 2015 Apr;
34(17):2514-27.
PMID: 25900819
Outcome-based sampling is an efficient study design for rare conditions, such as glioblastoma. It is often used in conjunction with matching, for increased efficiency and to potentially avoid bias due...
2.
DeSantis S, Houseman E, Coull B, Nutt C, Betensky R
Stat Med
. 2012 Apr;
31(13):1342-60.
PMID: 22495652
High-grade gliomas are the most common primary brain tumors in adults and are typically diagnosed using histopathology. However, these diagnostic categories are highly heterogeneous and do not always correlate well...
3.
Camelo-Piragua S, Jansen M, Ganguly A, Kim J, Cosper A, Dias-Santagata D, et al.
J Neuropathol Exp Neurol
. 2011 Feb;
70(2):110-5.
PMID: 21343879
One of the major challenges of surgical neuropathology is the distinction of diffuse astrocytoma (World Health Organization grade II) from astrocytosis. The most commonly used ancillary tool to solve this...
4.
Gordon F, Nutt C, Cheunsuchon P, Nakayama Y, Provencher K, Rice K, et al.
Endocrinology
. 2010 Apr;
151(6):2443-52.
PMID: 20392836
Maternally expressed gene 3 (MEG3) is a noncoding RNA highly expressed in the normal human brain and pituitary. Expression of MEG3 is lost in gonadotroph-derived clinically nonfunctioning pituitary adenomas. Meg3...
5.
Colman H, Zhang L, Sulman E, McDonald J, Shooshtari N, Rivera A, et al.
Neuro Oncol
. 2010 Feb;
12(1):49-57.
PMID: 20150367
Only a subset of patients with newly diagnosed glioblastoma (GBM) exhibit a response to standard therapy. To date, a biomarker panel with predictive power to distinguish treatment sensitive from treatment...
6.
Camelo-Piragua S, Jansen M, Ganguly A, Kim J, Louis D, Nutt C
Acta Neuropathol
. 2010 Jan;
119(4):509-11.
PMID: 20044756
No abstract available.
7.
Yip S, Miao J, Cahill D, Iafrate A, Aldape K, Nutt C, et al.
Clin Cancer Res
. 2009 Jul;
15(14):4622-9.
PMID: 19584161
Purpose: Over the past few years, the alkylating agent temozolomide has become the standard-of-care therapy for patients with glioblastoma, the most common brain tumor. Recently, large-scale cancer genome sequencing efforts...
8.
Lun X, Jang J, Tang N, Deng H, Head R, Bell J, et al.
Clin Cancer Res
. 2009 Apr;
15(8):2777-88.
PMID: 19351762
Purpose: The oncolytic effects of a systemically delivered, replicating, double-deleted vaccinia virus has been previously shown for the treatment of many cancers, including colon, ovarian, and others. The purpose of...
9.
de la Iglesia N, Konopka G, Lim K, Nutt C, Bromberg J, Frank D, et al.
J Neurosci
. 2008 Jun;
28(23):5870-8.
PMID: 18524891
Inactivation of the tumor suppressor phosphatase and tensin homolog (mutated in multiple advanced cancers 1) (PTEN) is recognized as a major event in the pathogenesis of the brain tumor glioblastoma....
10.
Mizoguchi M, Betensky R, Batchelor T, Bernay D, Louis D, Nutt C
J Neuropathol Exp Neurol
. 2006 Dec;
65(12):1181-8.
PMID: 17146292
Diffuse astrocytic gliomas are the most common human glial tumors with glioblastoma being the most malignant form. Epidermal growth factor receptor (EGFR) gene amplification is one of the most common...